학술논문
Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: A double-blind, placebo-controlled, randomized Phase II trial
Document Type
Article
Author
Source
In: BJU International . (BJU International, October 2010, 106(7):966-973)
Subject
Language
English
ISSN
14644096
1464410X
1464410X